Datamed GmbH

Cologne 50935

0 studies enrolling now · 3 studies all time

What they study most

Migraine, Multiple Sclerosis

Studies at this site

• Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens — Completed
• Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis — Status unconfirmed
• Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed